Patents by Inventor Shivkumar Mahadevan

Shivkumar Mahadevan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210190992
    Abstract: Provided is a contact lens system that comprises: a contact lens containing a photosensitive chromophore and a package surrounding the contact lens. The photosensitive chromophore has at least one active wavelength between 250 and 400 nanometers and at least one active wavelength between 400 and 450 nanometers. The package has a transmittance of no more than 99 percent at each active wavelength.
    Type: Application
    Filed: November 19, 2020
    Publication date: June 24, 2021
    Inventors: Patricia Martin, Shivkumar Mahadevan
  • Publication number: 20210179766
    Abstract: Provided are ophthalmic devices comprised of a reaction product of a composition comprising: (i) a crosslinked substrate network containing covalently bound activatable free radical initiators; and (ii) a grafting composition containing one or more ethylenically unsaturated compounds. Also provided are processes for making ophthalmic devices.
    Type: Application
    Filed: February 25, 2021
    Publication date: June 17, 2021
    Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
  • Patent number: 11021558
    Abstract: Provided are polymer compositions made by a process comprising: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator, (c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and a
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: June 1, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
  • Publication number: 20210109255
    Abstract: Described are polymerizable high energy light absorbing compounds. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
    Type: Application
    Filed: December 3, 2020
    Publication date: April 15, 2021
    Inventors: Shivkumar Mahadevan, Dawn D. Wright
  • Patent number: 10975040
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxyphenyl naphthotriazole structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxyphenyl naphthotriazole structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: April 13, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Patent number: 10961341
    Abstract: Provided are ophthalmic devices comprised of a reaction product of a composition comprising: (i) a crosslinked substrate network containing covalently bound activatable free radical initiators; and (ii) a grafting composition containing one or more ethylenically unsaturated compounds. Also provided are processes for making ophthalmic devices.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: March 30, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
  • Publication number: 20210063770
    Abstract: Described are multifocal contact lenses that contain high energy visible (HEV) light absorbing compounds and their use for improving one or more vision attributes.
    Type: Application
    Filed: July 24, 2020
    Publication date: March 4, 2021
    Inventors: Shivkumar Mahadevan, Dawn D. Wright, Ronald J. Clark, Thomas R. Karkkainen, Derek Nankivil
  • Publication number: 20210061934
    Abstract: Described are contact lenses that contain high energy visible (HEV) light absorbing compounds and their use for improving one or more vision attributes.
    Type: Application
    Filed: July 24, 2020
    Publication date: March 4, 2021
    Inventors: Patricia Martin, John R. Buch, Jessica Cannon, Shivkumar Mahadevan, Dawn D. Wright
  • Patent number: 10935695
    Abstract: Described are polymerizable high energy light absorbing compounds. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: March 2, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Dawn D. Wright
  • Publication number: 20210016527
    Abstract: The present invention relates to a method of manufacturing a contact lens including the steps of: (i) adding reactive components to a mold, wherein the reactive components comprise (a) at least one hydroxy-containing silicone component having a weight average molecular weight from about 200 to about 15,000 g/mole and (b) at least one mono-ether terminated, mono-methacrylate terminated polyethylene glycol having a weight average molecular weight from about 200 to about 10,000 g/mole; (ii) curing the reactive components within the mold to form the contact lens; and (iii) removing the contact lens from said mold.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Inventors: Azaam Alli, Shivkumar Mahadevan
  • Publication number: 20200407337
    Abstract: Described are visible light absorbing compounds. The compounds have a visible light absorption maximum between 430 and 480 nm and a full width half maximum (FWHM) at the visible light absorption maximum of at least 35 nm and up to 100 nanometers, wherein the compounds are photostable. The compounds substantially mimic the visible light absorbance properties of macular pigment while remaining photostable. The compounds may be used in a variety of articles, including ophthalmic devices.
    Type: Application
    Filed: June 11, 2020
    Publication date: December 31, 2020
    Inventor: Shivkumar Mahadevan
  • Publication number: 20200407324
    Abstract: Described are polymerizable fused tricyclic compounds of formula I: wherein R1, R2, R3, m, n, t, and rings B, C, and D are as defined herein. The compounds absorb various wavelengths of ultraviolet and/or visible light (such as high energy visible light) and are suitable for incorporation in a variety of products, such as biomedical devices and ophthalmic devices.
    Type: Application
    Filed: May 26, 2020
    Publication date: December 31, 2020
    Inventors: Shivkumar Mahadevan, Dawn D. Wright
  • Patent number: 10792874
    Abstract: The present invention relates to a method of manufacturing a contact lens including the steps of: (i) adding reactive components to a mold, wherein the reactive components comprise (a) at least one hydroxy-containing silicone component having a weight average molecular weight from about 200 to about 15,000 g/mole and (b) at least one mono-ether terminated, mono-methacrylate terminated polyethylene glycol having a weight average molecular weight from about 200 to about 10,000 g/mole; (ii) curing the reactive components within the mold to form the contact lens; and (iii) removing the contact lens from said mold.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: October 6, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Shivkumar Mahadevan
  • Patent number: 10752720
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxybiphenyl benzotriazole structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxybiphenyl benzotriazole structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: August 25, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Patent number: 10723732
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxyphenyl phenanthroline structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxyphenyl phenanthroline structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: July 28, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Patent number: 10676575
    Abstract: Described is a tri-block prepolymer having a chemical structure of [A]-[B]-[C], comprising at least one monovalent reactive group, wherein segment [A] and [C] independently comprise polymeric segments based on a first hydrophilic monomer comprising functionality selected from the group consisting of hydroxyalkyl, alkylamine, and mixtures thereof and optionally a second hydrophilic monomer, and [B] comprises a polymeric segment of at least one silicone-containing macromer and optionally a third hydrophilic monomer comprising functionality selected from the group consisting of hydroxyalkyl, alkylamine, and mixtures thereof and optionally a silicone-containing monomer. These prepolymers may be used alone or in combination with other components in reactive monomer mixtures for making silicone hydrogels and ophthalmic devices made therefrom, including contact lenses.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: June 9, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Yong Zhang, Scott L. Joslin, Shivkumar Mahadevan, James D. Ford
  • Patent number: 10661964
    Abstract: A packaging for an ophthalmic lens containing a pharmaceutical agent.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: May 26, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Michael Tokarski, Shivkumar Mahadevan, Scott Ansell, Vincent Barre
  • Publication number: 20200095187
    Abstract: Described are polymerizable high energy light absorbing compounds of formula I: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and X are as described herein. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
    Type: Application
    Filed: August 22, 2019
    Publication date: March 26, 2020
    Inventors: Stephen C. Arnold, Shivkumar Mahadevan, Ghulam Maharvi
  • Publication number: 20200079743
    Abstract: Described are high energy light blocking compounds and ophthalmic devices containing the compounds. In particular, described are hydroxyphenyl naphthotriazole structures with polymerizable functionality that block high energy light and are visibly transparent. The hydroxyphenyl naphthotriazole structures can be incorporated into ophthalmic devices, such as hydrogel contact lenses, to protect eyes from high energy light radiation.
    Type: Application
    Filed: November 15, 2019
    Publication date: March 12, 2020
    Inventors: Shivkumar Mahadevan, Leilani K. Sonoda, Dola Sinha, Patricia Martin
  • Patent number: 10558062
    Abstract: Methods and apparatus to form biocompatible energization elements are described. In some embodiments, the methods and apparatus to form the biocompatible energization elements involve forming cavities comprising active cathode chemistry. The active elements of the cathode and anode are sealed with a laminate stack of biocompatible material. In some embodiments, a field of use for the methods and apparatus may include any biocompatible device or product that requires energization elements.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: February 11, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frederick A. Flitsch, Daniel B. Otts, Randall B. Pugh, James Daniel Riall, Adam Toner, Shivkumar Mahadevan